Stephen L. Collins
Corporate Officer/Principal presso Lev Pharmaceuticals, Inc.
Profilo
Stephen L.
Collins is Director-Distribution and Patient Services of Lev Pharmaceuticals, Inc. Previously, he was Senior Director-Managed Care and Customer Operations of MedImmune.
Prior to MedImmune, Mr. Collins was Regional Director of the Managed Care Team for Burroughs Wellcome.
Posizioni attive di Stephen L. Collins
| Società | Posizione | Inizio |
|---|---|---|
Lev Pharmaceuticals, Inc.
 Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY. | Corporate Officer/Principal | 26/06/2007 |
| County of Nassau (New York) | Treasurer | - |
Precedenti posizioni note di Stephen L. Collins
| Società | Posizione | Fine |
|---|---|---|
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
| Coopers & Lybrand LLP | Comptroller/Controller/Auditor | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
| Coopers & Lybrand LLP | Commercial Services |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company was founded on July 21, 2003 and is headquartered in New York, NY. | Health Technology |
| County of Nassau (New York) | Government |
- Borsa valori
- Insiders
- Stephen L. Collins
